Scottish Medtech Seluna Launches Pediatric Sleep Trial Ahead of U.S. Entry

▤ Summary

Seluna launched a pediatric sleep diagnostic validation study with the Royal Hospital for Children in Glasgow. The company is developing machine learning software as a medical device to automate sleep study scoring and improve diagnosis of childhood sleep apnea. It has raised more than $860,000 in recent funding and plans to use that capital for FDA pre-submission work, algorithm optimization, and its first UK trial. Seluna is also seeking U.S. partnerships with sleep clinics and pediatric hospitals, along with a lead U.S. investor for its upcoming seed round. The company expects the study program to support U.S. expansion and eventual Class II FDA approval.

$ Funding

▦ Linked Companies